Tags: Poolbeg PharmaPOLB 001Cytokine Release SyndromeCRSimmunotherapies
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Mary McDougall Financial Times Reporter @FinancialTimes. DMs open. London, England | ||
2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Poolbeg Pharma presents positive results for POLB 001 - 4 months ago Poolbeg’s cytokine release syndrome drug shows potential - about 1 year ago | |
3 | Maria Ward-Brennan City A.M. Senior Reporter at CityAM. Formerly at TheLawyerMag. Berkshire, England | ||
4 | Tarah Chieffi The Points Guy Senior Writer for The Points Guy
Covers travel | ||
5 | Thomas Macaulay Next Web Reporter at The Next Web. London, England | AI startup Poolside raises $500M as AI coding market booms - 6 months ago | |
6 | Siôn Geschwindt Next Web The Heart of Tech ❤️ Amsterdam, The Netherlands | ||
7 | Rhodri Morgan City A.M. Energy and commodities reporter for City AM. London | Costa Navarino: Greek golf hotspot is the stuff of legend - 8 months ago | |
8 | Jordan Fragen VentureBeat Adds context to gaming, esports data. Los Angeles, California | North Beach Games unveils Stranded Deep 2, Prague studio - 8 months ago | |
9 | Will Norman PV Tech Senior reporter. London | Voltalia buys majority stake in 60MW Dutch PV project - over 1 year ago | |
10 | Umesh Ellichipuram Power Technology Resources for power, energy industries. Worldwide | Dogger Bank A installs 328km of inter-array cables - 9 months ago |